Trainees (N=17) | ||
Level of training | PGY1 | 3 (18%) |
PGY2 | 4 (24%) | |
PGY3 | 4 (24%) | |
PGY4 | 3 (18%) | |
PGY5 | 1 (6%) | |
PGY6 | 2 (12%) | |
Are you a graduating resident/fellow? | Yes | 5 (29%) |
No | 12 (71%) | |
Were you redeployed to a COVID-19 unit? | Yes | 9 (53%) |
No | 8 (4%) | |
Did you test positive for COVID-19 or were you suspected to have COVID-19? | Yes | 3 (18%) |
No | 14 (82%) | |
Faculty (N=25) | ||
Years of practice | 1–3 years | 4 (16%) |
4–10 years | 9 (36%) | |
11–20 years | 9 (36%) | |
>20 years | 3 (12%) | |
Subspecialty | Epilepsy | 3 (12%) |
General neurology | 1 (4%) | |
Headache and facial pain | 1 (4%) | |
Movement disorders | 1 (4%) | |
Multiple sclerosis/autoimmune | 2 (8%) | |
Neuro-oncology | 2 (8%) | |
Neurocritical care | 1 (4%) | |
Neurocritical care/vascular | 1 (4%) | |
Neurointerventional | 1 (4%) | |
Neuromuscular | 7 (28%) | |
Neuromuscular/MS | 1 (4%) | |
Vascular neurology | 4 (16%) | |
Full time? | Yes | 24 (96%) |
No | 1 (4%) | |
Do you routinely interact with residents? | Yes | 24 (96%) |
No | 1 (4%) | |
In what capacity do you routinely interact with residents? | Mentorship | 17 (68%) |
Direct supervision in outpatient | 17 (68%) | |
Direct supervision in inpatient | 14 (56%) | |
Didactics | 20 (80%) | |
Research | 13 (52%) |
MS, multiple sclerosis; PGY, postgraduate year.